NCT00077597已完成3 期
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 182
- 主要终点
- Hemoglobin response rate
研究概览
简要总结
This study will assess the efficacy and safety of Mircera given intravenously in the treatment of renal anemia in chronic kidney disease patients on dialysis who are not currently receiving epoetin or any other erythropoietic substance. The anticipated time on study treatment is 1-2 years and the target sample size is 100-500 individuals.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adult patients >=18 years of age;
- •chronic renal anemia;
- •dialysis therapy for at least 2 weeks before screening.
排除标准
- •women who are pregnant, breastfeeding or using unreliable birth control methods;
- •administration of any investigational drug within 4 weeks before screening.
研究组 & 干预措施
1
Experimental
干预措施: methoxy polyethylene glycol-epoetin beta [Mircera] (Drug)
2
Active Comparator
干预措施: epoetin (Drug)
结局指标
主要结局
Hemoglobin response rate
时间窗: Weeks 1-24
次要结局
- Hb over time, time to target Hb response, incidence of RBC transfusions. Vital signs, ECG, AEs, laboratory values\n(Throughout study)
研究者
相似试验
已完成
3 期
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis PatientsAnemiaNCT00081484Hoffmann-La Roche336
已完成
3 期
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.AnemiaNCT00413894Hoffmann-La Roche424
已完成
2 期
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal AnemiaAnemiaNCT00048035Hoffmann-La Roche91
已完成
2 期
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.AnemiaNCT00364832Hoffmann-La Roche137
已完成
3 期
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis PatientsAnemiaNCT00077610Hoffmann-La Roche673
